These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 34912413)

  • 1. Clinical effects of Apatinib combined with DOS neoadjuvant chemotherapy regimen in neoadjuvant chemotherapy for LAGC.
    Zhou PZ; Gao L; Wu W; Hao YX
    Pak J Med Sci; 2021; 37(7):1890-1895. PubMed ID: 34912413
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neoadjuvant apatinib plus tegafur/gimeracil/oteracil potassium (S‑1)/oxaliplatin chemotherapy vs. chemotherapy alone in patients with locally advanced gastric carcinoma.
    Wang Z; He T; Yu D; Qin X; Geng A; Yang H
    Exp Ther Med; 2022 Oct; 24(4):625. PubMed ID: 36160880
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perioperative Safety and Effectiveness of Neoadjuvant Therapy with Fluorouracil, Leucovorin, Oxaliplatin, and Docetaxel Plus Apatinib in Locally Advanced Gastric Cancer.
    Zhang Y; Zhang B; Yang J; Zhang J; Zhang W
    Cancer Manag Res; 2021; 13():2279-2286. PubMed ID: 33732020
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neoadjuvant PD-1 inhibitor plus apatinib and chemotherapy versus apatinib plus chemotherapy versus chemotherapy alone in patients with locally advanced gastric cancer.
    Xiong H; Li Y
    Am J Cancer Res; 2023; 13(8):3559-3570. PubMed ID: 37693166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low-dose apatinib combined with camrelizumab and the SOX regimen in the neoadjuvant treatment of locally advanced gastric/gastroesophageal junction adenocarcinoma (SPACE-neo): a protocol for an open-label, single-arm, clinical trial.
    Pan L; Tian Y; Wang K; Tang J; Liu J; Zhang J; Wang M; Liu J; Xu H; Chen X
    J Gastrointest Oncol; 2022 Dec; 13(6):3300-3313. PubMed ID: 36636043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of Docetaxel + Oxaliplatin + S-1 vs Oxalipatin + S-1 as Neoadjuvant Chemotherapy for Locally Advanced Gastric Cancer: A Propensity Score Matched Analysis.
    Zhang X; Huang H; Wei Z; Zhu Z; Yang D; Fu H; Xu J; Hu Z; Zhang Y; You Q; Huang X; Yan R; Wang W; Cai Q
    Cancer Manag Res; 2020; 12():6641-6653. PubMed ID: 32801898
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of oxaliplatin and tigio combination therapy in locally advanced gastric cancer.
    Wang T; Zhang LY
    World J Gastrointest Surg; 2024 Jun; 16(6):1709-1716. PubMed ID: 38983324
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of apatinib combined with tegafur gimeracil and oteracil potassium in the second-line treatment of advanced gastric cancer.
    Chen H; Xue L; Liu L; Li P
    J BUON; 2021; 26(3):917-923. PubMed ID: 34268954
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Two therapeutic regimens for advanced gastric carcinoma: DOS chemotherapy alone vs. trastuzumab combined with DOS.
    Jiang N; Chen J; Jin Y
    J BUON; 2021; 26(3):904-910. PubMed ID: 34268952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of IgG, IgM, CD4+ and CD8+ T cells during neoadjuvant chemotherapy with Tezio and Apatinib in gastric cancer patients.
    Cui Z; Zhang J; Zhang J; Xu L
    Cell Mol Biol (Noisy-le-grand); 2020 Jun; 66(3):113-118. PubMed ID: 32538756
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neoadjuvant PD-1 Inhibitor Plus Apatinib and Chemotherapy Versus Apatinib Plus Chemotherapy in Treating Patients With Locally Advanced Gastric Cancer: A Prospective, Cohort Study.
    Wang C; Wang Z; Zhao Y; Wang F
    J Gastric Cancer; 2023 Apr; 23(2):328-339. PubMed ID: 37129156
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Observation on the Clinical Effect of Apatinib Combined with Chemotherapy in the Treatment of Advanced Non-Small Cell Lung Cancer.
    Cui YJ; Liu J; Liu MM; Zhang HZ
    Pak J Med Sci; 2021; 37(4):1036-1041. PubMed ID: 34290779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Safety and effectiveness of oxaliplatin combined with capecitabine or oxaliplatin combined with S-1 neoadjuvant chemotherapy in the treatment of advanced gastric cancer].
    Xie BW; Zang L; Ma JJ; Sun J; Yang X; Wang ML; Lu AG; Hu WG; Zheng MH
    Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Feb; 24(2):138-144. PubMed ID: 33508919
    [No Abstract]   [Full Text] [Related]  

  • 14. Surgical Efficacy and Safety of Patients with Locally Advanced Gastric Cancer following Neoadjuvant Concurrent Chemoradiotherapy and Chemotherapy.
    Li CC; Yeh YS; Chen YC; Su WC; Chang TK; Tsai HL; Huang CW; Ma CJ; Yin TC; Chen PJ; Wang JY
    J Oncol; 2022; 2022():3719241. PubMed ID: 35345514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neoadjuvant Bevacizumab Plus Docetaxel/Cisplatin/Capecitabine Chemotherapy in Locally Advanced Gastric Cancer Patients: A Pilot Study.
    Yu D; Wang Z; He T; Yang L
    Front Surg; 2022; 9():842828. PubMed ID: 35647008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical study of apatinib combined with chemotherapy for advanced non-small cell lung cancer with negative driving genes].
    Li YF; Jiang HY; Li Q; Zhu M; Lyu J; Zhao HY
    Zhonghua Zhong Liu Za Zhi; 2019 Oct; 41(10):775-781. PubMed ID: 31648501
    [No Abstract]   [Full Text] [Related]  

  • 17. A phase II study of neoadjuvant docetaxel, oxaliplatin, and S-1 (DOS) chemotherapy followed by surgery and adjuvant S-1 chemotherapy in potentially resectable gastric or gastroesophageal junction adenocarcinoma.
    Park I; Ryu MH; Choi YH; Kang HJ; Yook JH; Park YS; Kim HJ; Jung HY; Lee GH; Kim KC; Kim BS; Kang YK
    Cancer Chemother Pharmacol; 2013 Oct; 72(4):815-23. PubMed ID: 23921575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is serum survivin expression a predictive biomarker in locally advanced gastric cancer patients treated with neoadjuvant chemotherapy?
    Bozkaya Y; Özdemir NY; Sezer S; Köstek O; Demirci NS; Yazıcı O; Erdem GU; Eren T; Zengin N
    Cancer Biomark; 2018; 22(1):143-149. PubMed ID: 29562501
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic effects and safety of apatinib mesylate on patients with gastric carcinoma peritoneal metastasis in SOX scheme.
    Wang HF; Wang HH; Ye XJ; Wang WJ; Teng LS
    Eur Rev Med Pharmacol Sci; 2023 Jul; 27(14):6627-6638. PubMed ID: 37522674
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical curative effect of neoadjuvant chemotherapy combined with immunotherapy and its impact on immunological function and the expression of ER, PR, HER-2 & SATB1 in HER-2-Positive breast cancer patients.
    Chen Z; Sang MX; Geng CZ; Hao W; Jia HQ
    Pak J Med Sci; 2022; 38(3Part-I):553-559. PubMed ID: 35480523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.